 |
|
An Epigenetically Derived Monoclonal Origin for Recurrent Respiratory Papillomatosis
Josena Kunjoonju Stephen, MD;
Lori E. Vaught, MD;
Kang Mei Chen, MD;
Veena Shah, MD;
Vanessa G. Schweitzer, MD;
Glendon Gardner, MD;
Michael S. Benninger, MD;
Maria J. Worsham, PhD
Arch Otolaryngol Head Neck Surg. 2007;133(7):684-692.
Objective To investigate the contribution of promoter methylation-mediated epigenetic events in recurrent respiratory papillomatosis tumorigenesis.
Design Archival tissue DNA, extracted from microdissected papilloma lesions, was interrogated for methylation status by means of the novel, multigene methylation-specific multiplex ligation-dependent probe amplification assay.
Subjects Fifteen subjects with recurrent respiratory papillomatosis, 3 females and 12 males, all with adult onset of illness (age range, 23-73 years) except for 1 female patient with juvenile onset (1 year old).
Results Promoter hypermethylation was recorded in 14 of 15 cases, and 19 of 22 unique methylation-prone cancer genes in the multigene panel had altered DNA methylation in at least 1 laryngeal papilloma biopsy specimen. Identical abnormally methylated genes were found in 5 of 15 recurrent cases, of which the CDKN2B gene was hypermethylated in all 5 cases. Dissimilar epigenetic events were noted in the remaining cases.
Conclusions A clonal origin was derived for 5 of 15 recurrent respiratory papillomatosis biopsy specimens based on identical epigenetic events. The high frequency of epigenetic events, characterized by consistent promoter hypermethylation of multiple tumor suppressor genes, points to the use of gene silencing mechanisms in the pathogenesis of recurrent respiratory papillomatosis.
Author Affiliations: Research Division, Department of Otolaryngology–Head and Neck Surgery (Drs Stephen, Vaught, Chen, Schweitzer, Gardner, Benninger, and Worsham), and Department of Pathology (Dr Shah), Henry Ford Hospital, Detroit, Michigan.
|
